NasdaqCM - Nasdaq Real Time Price
USD
Intensity Therapeutics, Inc. (INTS)
3.0000
-0.1000
(-3.23%)
At close: November 6 at 4:00:00 PM EST
3.0000
0.0000
(0.00%)
Overnight: 9:05:59 PM EST
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
Key Executives
Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Lewis H. Bender M.A., M.B.A., M.S.
|
Founder, President, CEO & Chairman of the Board | 1.02M | -- | 1959 |
|
Mr. Joseph Talamo CPA, M.B.A.
|
Chief Financial Officer | 576.01k | -- | 1969 |
|
Mr. John Wesolowski CPA, M.B.A.
|
Principal Accounting Officer & Controller | 329.21k | -- | 1960 |
|
Mr. James M. Ahlers
|
Executive Vice President of Corporate Finance | 75.09k | -- | 1964 |
Intensity Therapeutics, Inc.
1 Enterprise Drive
Suite 430
Shelton, CT 06484-4779
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 5
Description
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer relapse and metastasis in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.
Corporate Governance
Intensity Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of
Institutional Shareholder Services (ISS)
Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
